NCT03882528View on ClinicalTrials.gov

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

April 25, 2019

Study Completion Date

May 16, 2019

Conditions
Malaria,Falciparum
Interventions
BIOLOGICAL

Plasmodium falciparum malaria parasite

Laboratory cultured Plasmodium falciparum strain 3D7 delivered via the bite of 5 infected mosquitoes with salivary gland scores of at least 2+ (11-100 sporozoites observed).

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

All Listed Sponsors
lead

U.S. Army Medical Research and Development Command

FED

NCT03882528 - Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 | Biotech Hunter | Biotech Hunter